Karen Dawes

Ms. Karen T. Dawes is an Independent Director at Vaccitech (UK) Ltd., an Independent Director at PaxMedica, Inc., a Chairman at Repligen Corp. and a President at Knowledgeable Decisions LLC. She is on the Board of Directors at Vaccitech (UK) Ltd., PaxMedica, Inc., Medicenna Therapeutics Corp., Symbiomix Therapeutics LLC, Medicines 360, Seaside Therapeutics LLC and Vaccitech Plc. Ms. Dawes was previously employed as an Independent Director by Assertio Therapeutics, Inc., a Chairman by PDL BioPharma, Inc., a Senior Vice President & Head-US Business Group by Bayer Corp., a Senior Vice President by Wyeth Pharmaceuticals, Inc., a Chief Commercial Officer by Genetics Institute, Inc., a Vice President-Marketing by Pfizer Inc., and a Senior Vice President-Global Strategic Marketing by Wyeth Corp. She also served on the board at Inspiration Biopharmaceuticals, Inc., Protein Design Labs, Inc. and Genaissance Pharmaceuticals, Inc. She received her undergraduate degree from Simmons University, a graduate degree from Simmons University and an MBA from Harvard University.